Scholars Central

Conference abstract

Re-thinking vaccinology

Authors: Geert Vanden Bossche

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

T o eliminate safety risks related to infectivity, inactivated pathogens and, more suitably, well-characterized pathogen- derived antigens (Ags) have increasingly been used as immunogens in ?modern? vaccines. The selection of these Ags is usually based on their capacity to naturally induce immune responses that ?correlate? with protection.. These Ags, however, are known to be antigenically variable (e.g., conformational Bc epitopes) and/ or subject to immunogenetic restriction (e.g., linear, cell-bound epitopes). In addition, the immunogenicity of ?good? vaccinal Ags is largely dependent on memory CD4 + T helper cells. However, activation of the latter upon natural infection or foreign Ag exposure of genetically predisposed subjects has been associated with immune pathology. Priming of CD4 + T helper cells by adjuvanted vaccines is, therefore, increasingly raising safety concerns. On the other hand, Ags that are highly conserved and of vital importance to the pathogen (hence, called ?protective?) are either not included in contemporary vaccines or not effectively recognized by the host immune system since either deprived of cognate CD4 + T help or outcompeted by other pathogen-derived ?decoy? epitopes for binding to MHC molecules. Hence, we consider that new technologies enabling immune targeting of such protective epitopes by natural, universal (i.e., MHC-nonrestricted) immune helper cells is the new Holy Grail for modern vaccinology.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Vaccines & Vaccination.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Vaccines & Vaccination
  • SubjectVaccines & Immunisation
  • BylineArticles whose byline prints “Geert Vanden Bossche”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels